Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q1 Adjusted EBITDA Up At SEK 6.3 Mln

April 21 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * INTERIM REPORT JANUARY-MARCH 2021
    * Q1 ADJUSTED OPERATING PROFIT BEFORE DEPRECIATION AND
AMORTIZATION (EBITDA) AMOUNTED TO SEK 6.3 MILLION (5.1)
    * Q1 NET SALES AMOUNTED TO SEK 58.3 MILLION (46.5)

Source text for Eikon:  ID:nMFN9G0CWH 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Xvivo Perfusion AB

See all news